MED Dec 2024 17.500 call
| Previous close | 5.89 |
| Open | 5.89 |
| Bid | 5.40 |
| Ask | 5.90 |
| Strike | 17.50 |
| Expiry date | 2024-12-20 |
| Day's range | 5.89 - 5.89 |
| Contract range | N/A |
| Volume | |
| Open interest | 6 |
- Business Wire
Medifast Named as One of The "Best Companies To Work For" by U.S. News & World Report
BALTIMORE, June 17, 2024--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA®, today announced that it has been recognized in the 2024-2025 rankings by U.S. News & World Report as one of the nation’s "Best Companies to Work For" in the food and drink industry. This recognition marks Medifast’s second straight year of inclusion on the list and underscores the company’s ongoing commitment to creating an outstanding workplace
Simply Wall St.Are Medifast, Inc. (NYSE:MED) Investors Paying Above The Intrinsic Value?
Key Insights The projected fair value for Medifast is US$16.13 based on 2 Stage Free Cash Flow to Equity Current share...
ZacksMedifast (MED) Tumbles More Than 40% in 3 Months: Here's Why
Medifast (MED) battles persistent customer acquisition challenges aggravated by macroeconomic factors and the rising popularity of weight loss medications.
